STOCKS TELEGRAPH

Tag: Trinity Biotech plc

  • Investor Confidence Rises As Trinity Biotech (TRIB) Announces Strategic Acquisitions

    Investor Confidence Rises As Trinity Biotech (TRIB) Announces Strategic Acquisitions

    Following the announcement of significant acquisition and investment initiatives, Trinity Biotech plc (NASDAQ: TRIB) shares are on a notable surge on the charts. As of the last check, TRIB stock was trading 10.43% higher reaching a price of $2.02. This uptick reflects investor confidence in the company’s strategic direction and growth potential.

    Acquisition of EpiCapture Limited

    Trinity Biotech (TRIB) made a significant acquisition when it bought EpiCapture Limited, a company that specializes in creating a non-invasive test to track the risk of aggressive prostate cancer. Trinity Biotech’s strategic entry into the cancer diagnostics industry is marked by this purchase, which puts the business in a position to meet a significant unmet medical need.

    By using epigenetic analysis to find DNA methylation patterns linked to high-grade malignancies, the EpiCapture test may lower the need for intrusive procedures while improving patient outcomes.

    Using Knowledge to Make Progress

    Trinity Biotech plans to harness its extensive manufacturing expertise and the capabilities of its New York State Department of Health-certified Immco reference laboratory to propel the development and commercialization of EpiCapture’s innovative technology.

    By applying its 30 years of experience in diagnostic product optimization, Trinity aims to bring the EpiCapture test to market in the United States while also evaluating regulatory pathways for broader global distribution.

    Strategic Investment in Novus Diagnostics

    In addition to the EpiCapture acquisition, Trinity Biotech has announced a strategic investment in Novus Diagnostics, a company that is at the forefront of creating a rapid sepsis testing platform.

    This investment aims to expedite the development and market entry of Novus’ innovative point-of-care diagnostic solutions, which include a groundbreaking 15-minute bloodstream infection test.

    Recognized as a critical advancement in diagnostics, rapid sepsis detection aligns with Trinity Biotech’s commitment to tackling urgent clinical challenges and demonstrates its ability to leverage manufacturing and regulatory expertise to facilitate the commercialization of essential diagnostic tools.

    With this support, Trinity Biotech anticipates Novus will accelerate its path to regulatory approval and market launch, further enhancing the company’s portfolio in the diagnostic landscape.

  • Revised Sales Forecast Triggers Trinity Biotech (TRIB) Stock Market Rally

    Revised Sales Forecast Triggers Trinity Biotech (TRIB) Stock Market Rally

    Shares of Trinity Biotech plc (NASDAQ: TRIB) have lately experienced a notable surge in value on the US stock market. At the time of the most recent market check, the stock has increased by a significant 53.50% to $3.07 per share. This spike comes after the business revised its sales projection upward, indicating significant market confidence.

    Trinity Biotech Enhances Sales Projection And Manufacturing Capability

    Trinity Biotech, a business that has historically provided quick HIV tests to markets in dire need, has shown a notable rise in orders for its TrinScreen HIV product. Trinity Biotech effectively increased its production capacity in response to the increased demand, which caused the business to update its TrinScreen HIV sales revenue prediction for 2024 from $8 million to about $10 million. This tactical shift highlights the business’s capacity to maintain a strong supply chain and react quickly to market needs.

    Manufacturing Growth To Meet New Health Needs

    Trinity Biotech is not only concentrating on HIV testing but also increasing the amount of its FDA-approved viral transport medium, FlexTrans, that it produces. This action is being taken in anticipation of a possible increase in demand as a result of the recent designation of mpox as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO). Trinity Biotech has demonstrated a strong dedication to tackling global health concerns through creative solutions, as seen by its proactive approach to manufacturing.

    TRIB Made New Leadership Appointment To Promote Growth

    David Ouston has been named as the Biosensor Marketing Director by Trinity Biotech, which is further strengthening its expansion plan. Mr. Ouston has a wealth of expertise propelling the expansion of glucose monitoring devices into international markets. Trinity Biotech will benefit greatly from his experience in global leadership and market access strategies for diabetes care as it gets ready to launch its own continuous glucose monitoring (CGM) technology.

    With the potential to have a big influence on the quickly expanding diabetes and wellness sectors, this technology is a promising advancement in wearable biosensor technology and wellness analytics. Recent advancements by Trinity Biotech place the business in a prominent position to advance public health via innovative technologies and calculated market expansion.

  • What changed for these 46 stocks in Pre Market Session?

    What changed for these 46 stocks in Pre Market Session?

    Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the next generation.

    Cinedigm Corp. (NASDAQ: CIDM) shares are trading down -4.55% at $0.525 at the time of writing after it posted Second Quarter Fiscal 2021 Earnings. The company’s 52-week range was noted as $0.25 to $6.00. Analysts have a consensus price target of $3.50.

    iBio Inc. (IBIO) tumbled over -2.34% at $1.67 in pre-market trading today as the Company revealed fiscal first quarter 2021 Financial results and provides a business update.

    CBAK Energy Technology Inc. (CBAT), an Electrical Equipment & Parts company, dropped about -7.4% at $9.01 in pre-market trading Wednesday.

    Comstock Mining Inc. (LODE) stock moved down -1.96 percent to $1.0 in the pre-market trading as it revealed to Host Earnings Call.

    CureVac N.V. (CVAC) lost over -3.01% at $74.19 in pre-market trading Wednesday 18 November 2020 after the news that the Company has established a European-based network to ramp Up manufacturing of its COVID-19 vaccine candidate, CVnCoV.

    Oncternal Therapeutics Inc. (ONCT) is down more than -24.88% at $3.11 in pre-market hours Wednesday 18 November 2020 as the Company increases previously revealed bought deal to $22.5 million. The stock had dropped over -9.41% to $4.14 in the last trading session.

    Before the trading started on 18 November 2020, New Concept Energy Inc. (GBR) is down -11.38% to reach $1.48 after the firm announced its Q3, 2020 results. It has been trading in a 52-week range of $0.55 to $2.19.

    Polar Power Inc. (POLA) stock plunged -7.25% to $3.07 in the pre-market trading. The most recent rating by ROTH Capital, on November 07, 2017, is at a Neutral.

    Trinity Biotech plc (NASDAQ: TRIB) shares are trading down 0.0% at $2.9 at the time of writing. The company’s 52-week range was noted as $0.56 to $3.35 as the company set to Host an Earnings Call.

    So-Young International Inc. (SY) grew over 4.65% at $13.5 in pre-market trading today as the company said it is going to report its earnings to result on November 25, 2020.

    BioNTech SE (BNTX), a Biotechnology company, rose about 4.22% at $90.6 in pre-market trading Wednesday after the report that Pfizer and BioNTech planned to file as vaccine proves 95% effective.

    Sunworks Inc. (SUNW) stock moved down -4.91 percent to $3.68 in the pre-market trading after the Company revealed that the proposed merger with the Peck Company Holdings, Inc. failed to secure stockholder approval.

    Sundial Growers Inc. (SNDL) lost over -3.04% at $0.2424 in pre-market trading Wednesday 18 November 2020 following the announcement of its third-quarter earnings results.

    Tuniu Corporation (TOUR) is up more than 1.04% at $1.95 in pre-market hours Wednesday 18 November 2020. The stock had dropped over -3.98% to $1.93 in the last trading session.

    Before the trading started on 18 November 2020, Taiwan Semiconductor Manufacturing Company Limited (TSM) is up 3.22% to reach $98.79 following the report that Samsung heats up chip wars with the claim that it can catch TSMC by 2022. It has been trading in a 52-week range of $42.70 to $102.44.

    Hill International Inc. (HIL) stock plunged -5.49% to $1.55 in the pre-market trading as the company said that CEO Raouf Ghali and CFO Todd Weintraub are scheduled to present at the following investor conferences during the month of November.

    Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares are trading down -4.77% at $0.5615 at the time of writing after the preliminary results following vaccination of non-human primates with TNX-1800 a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 spike protein after vaccination. The company’s 52-week range was noted as $0.39 to $2.46. Analysts have a consensus price target of $4.

    Genius Brands International Inc. (GNUS) tumbled over -3.42% at $1.13 in pre-market trading today after the company revealed strategic takeover of ChizComm Ltd. and ChizComm Beacon Media.

    Medley Management Inc. (MDLY), an Asset Management company, rose about 33.73% at $9.0 in pre-market trading Wednesday announced third-quarter earnings results.

    China SXT Pharmaceuticals Inc. (SXTC) stock moved down -3.59 percent to $0.2603 in the pre-market trading.

    Camtek Ltd. (CAMT) lost over -3.64% at $19.05 in pre-market trading Wednesday 18 November 2020 following the news of the commencement of a proposed underwritten public offering of three million ordinary shares.

    Cellectis S.A. (CLLS) is up more than 5.58% at $20.8 in pre-market hours Wednesday 18 November 2020, after the firm announced the appointment of Kyung Nam-Wortman as Cellectis’ Executive Vice President, Chief Human Resources Officer. The stock had dropped over -1.79% to $19.70 in the last trading session.

    Before the trading started on 18 November 2020, TechnipFMC plc (FTI) is up 4.34% to reach $8.42 after the Company received notice to proceed with the EPC contract for Sempra LNG’s and IEnova’s Energía Costa Azul LNG facility. It has been trading in a 52-week range of $4.49 to $21.84.

    Li Auto Inc. (LI) stock soared 3.17% to $36.16 in the pre-market trading after the Company revealed the 3rd quarter of 2020 Earnings results. The most recent rating by Citigroup, on November 16, 2020, is at a Buy.

    BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) shares are trading down -2.47% at $2.76 at the time of writing. The company’s 52-week range was noted as $2.35 to $62.00.

    Neptune Wellness Solutions Inc. (NEPT) tumbled over -2.63% at $1.85 in pre-market trading today after the company posted 2nd quarter loss and missed the predictions.

    Livent Corporation (LTHM), a Specialty Chemicals company, rose about 4.19% at $15.9 in pre-market trading Wednesday following the report of Analysts revised their forecast after disappointing Earnings.

    Micro Focus International plc (MFGP) stock moved up 29.73 percent to $4.8 in the pre-market trading.

    Houghton Mifflin Harcourt Company (HMHC) gained over 5.63% at $3.0 in pre-market trading Wednesday 18 November 2020 after the Company announced financial results for the quarter ended September 30, 2020. The Company revealed its plan to explore the potential sale of HMH Books & Media, its Consumer Publishing business.

    Acasti Pharma Inc. (ACST) is up more than 3.81% at $0.218 in pre-market hours Wednesday 18 November 2020 as the Company offered a business update for Q2, 2020. The stock had jumped over 0.77% to $0.21 in the last trading session.

    Before the trading started on 18 November 2020, Canaan Inc. (CAN) is up 8.73% to reach $3.61. It has been trading in a 52-week range of $1.76 to $13.00.

    VAALCO Energy Inc. (EGY) stock soared 45.1% to $1.48 in pre-market trading.

    Liminal BioSciences Inc. (NASDAQ: LMNL) shares are trading up 11.37% at $4.31 at the time of writing posted third-quarter results. The company’s 52-week range was noted as $3.51 to $31.45.

    Carver Bancorp Inc. (CARV) grew over 3.89% at $6.95 in pre-market trading today.

    Vaxart Inc. (VXRT), a Biotechnology company, dropped about -2.47% at $5.53 in pre-market trading Wednesday after it publicized that it is set to host a Key Opinion Leader (KOL) panel for investors entitled “An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus?” on Thursday, November 19, 2020, at 12pm Eastern Time.

    SCWorx Corp. (WORX) stock moved down -3.64 percent to $1.06 in the pre-market trading.

    Sunoco LP (SUN) lost over -7.0% at $27.11 in pre-market trading Wednesday 18 November 2020 as the Company gained above 5% as Q3 Earnings topped predictions.

    NIO Limited (NIO) is up more than 3.78% at $48.35 in pre-market hours Wednesday 18 November 2020 as the Company revealed its Q3 loss less than expected, whiles sales topped predictions. The stock had jumped over 2.22% to $46.59 in the last trading session.

    Before the trading started on 18 November 2020, Ocugen Inc. (OCGN) is up 4.27% to reach $0.3029 as Company recently revealed Q3 results. It has been trading in a 52-week range of $0.17 to $0.96.

    Weidai Ltd. (WEI) stock soared 9.4% to $1.63 in the pre-market trading after the report that the Company regained compliance after receipt of NYSE Non-compliance letter regarding ADS trading price on October 20, 2020. The most recent rating by Morgan Stanley, on January 21, 2020, is at an Underweight.

    Magnolia Oil & Gas Corporation (NYSE: MGY) shares are trading up 2.99% at $6.2 at the time of writing after the Company missed Earnings predictions. The company’s 52-week range was noted as $3.23 to $13.28.

    Waitr Holdings Inc. (WTRH) grew over 13.68% at $3.24 in pre-market trading today as the Company beat the Earnings outlook.

    Norwegian Cruise Line Holdings Ltd. (NCLH), a Travel Services company, dropped about -6.17% at $20.7 in pre-market trading Wednesday after the company revealed the pricing of 40,000,000 ordinary shares.

    IZEA Worldwide Inc. (IZEA) stock moved up 5.49 percent to $0.77 in the pre-market trading as it revealed Q3 financial results.

    The Boeing Company (BA) gained over 3.53% at $217.46 in pre-market trading Wednesday 18 November 2020 after the report that Boeing’s 737 Max cleared to fly in the US after crashes.